89bio (ETNB)
NASDAQ:ETNB
US Market
Holding ETNB?
Track your performance easily

89bio (ETNB) Financial Statements

776 Followers

89bio Financial Overview

89bio's market cap is currently ―. The company's EPS TTM is $-2.91; its P/E ratio is -2.72; 89bio is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is $-0.76. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -146.51M$ -46.96M$ -50.72M$ -35.50M$ -33.77M
EBITDA$ -146.14M$ -43.78M$ -50.71M$ -35.49M$ -33.76M
Net Income Common Stockholders$ -149.07M$ -47.97M$ -51.68M$ -40.23M$ -34.73M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 423.77M$ 531.38M$ 562.29M$ 578.87M$ 251.93M
Total Assets$ 458.30M$ 582.14M$ 577.32M$ 596.27M$ 460.11M
Total Debt$ 37.57M$ 27.35M$ 27.30M$ 27.11M$ 24.87M
Net Debt$ -386.21M$ -504.04M$ -534.99M$ -551.76M$ -227.06M
Total Liabilities$ 80.19M$ 67.22M$ 66.78M$ 59.96M$ 49.90M
Stockholders Equity$ 378.10M$ 514.90M$ 510.55M$ 536.31M$ 410.21M
Cash Flow-
Free Cash Flow$ -145.36M$ -61.16M$ -39.72M$ -34.30M$ -30.36M
Operating Cash Flow$ -145.36M$ -61.16M$ -39.72M$ -34.29M$ -30.36M
Investing Cash Flow$ -8.64M$ 27.85M$ -79.90M$ -63.64M$ 38.33M
Financing Cash Flow$ 33.19M$ 27.96M$ 21.03M$ 162.17M$ -1.48M
Currency in USD

89bio Earnings and Revenue History

89bio Debt to Assets

89bio Cash Flow

89bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis